Data / Form D filings / Solid Biosciences Inc.
Solid Biosciences Inc.: Form D filings
Solid Biosciences Inc., a pharmaceuticals company in Charlestown, MA, filed 3 Form D notices with the SEC between 2019 and 2022. The latest, on December 9, 2022, reports $9.2 million sold of a $9.2 million offering to 13 investors.
Find out what Solid Biosciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, Charlestown, MA, 02129
- Phone
- (617) 337-4680
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1707502
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 9, 2022 | New notice | $9,200,000 | $9,200,000 | $0 | 13 | Dec 2, 2022 | sec.gov |
| Oct 26, 2020 | New notice | $39,999,996 | $39,999,996 | $0 | 1 | Oct 22, 2020 | sec.gov |
| Jul 31, 2019 | New notice | $59,977,035 | $59,977,035 | $0 | 15 | Jul 30, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lynne Tyronne Sullivan | Director | |
| Adam Tyronne Koppel | Director | |
| Stephen DiPalma | Executive Officer | |
| Martin Tyronne Freed | Director | |
| Alexander (Bo) Cumbo | Executive Officer, Director | |
| Paul Tyronne Herizch | Executive Officer | |
| Clare Tyronne Kahn | Director | |
| Georgia Tyronne Keresty | Director | |
| Adam Tyronne Stone | Director | |
| Rajeev Tyronne Shah | Director | |
| Robert Tyronne Huffines | Director | |
| Carl Morris | Executive Officer | |
| Jessie Tyronne Hanrahan | Executive Officer | |
| Sukumar Tyronne Nagendran | Director | |
| Ilan Tyronne Ganot | Director | |
| David Tyronne Howton | Executive Officer | |
| Jennifer Marlowe | Executive Officer | |
| Ian Tyronne Smith | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Dec 5, 2022 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Solid Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.